A non-invasive, easy-to-use test, like the Cologuard test, is a simple and effective way to screen for colorectal cancer. In ...

The in-vitro colorectal cancer screening tests market is set for significant growth, driven by advancements in diagnostics ...

The kit, a fecal immunochemical test (FIT), uses antibodies to detect blood in stool. This blood is an early warning sign of colon cancer, and those who test positive are urged to undergo a ...

The researchers report in JAMA Network Open that mailing at-home colorectal cancer screening kits and providing coordinated follow-up led by an academic cancer center tripled screening completion ...

While bowel cancer – or colorectal cancer – has traditionally been more common in people over the age of 50, cases in the ...

Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal ...

The World Health Organization estimates that around 900,000 people each year die of colorectal ... that CEA screening lacks sensitivity, missing about half of CRC recurrences 2. Cancer researchers ...

(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...

Currently used urine test kits have low sensitivity, and cystoscopy ... KAIST develops technology to convert colorectal ...

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has ...

Ex-NFL players and the Centers for Disease Control and Prevention (CDC) are about to “Gear Up Against Cancer,” ...